Corium Therapeutics and Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical completed acquisition of AZSTARYS from Corium Therapeutics
Company-confirmed: reported in the company's own SEC filing
Latest update Aug 6, 2026, 11:33 AM ET
- ✓Announced
- ✓Pending
- ✓Completed
Target
Corium TherapeuticsNot US-listed- Deal value
- Not disclosed
- the filing states none
- Offer
- Not disclosed
- Premium
- N/A
- Shown only for a signed all-cash price per share
- Expected close
- Not disclosed
- other
Share prices around the disclosure
Daily closes, each set to 100 on the first day shown. The dashed lines mark the session that first reflects each public event.